Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pan

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Neurology|September 13, 2021
Cognitive Impairment After Intracerebral Hemorrhage: A Systematic Review of Current Evidence and Knowledge GapsThomas Potter, Vasileios-Arsenios Lioutas, Mauricio Tano, et al.
Stroke|February 3, 2022
Contemporary Trends in the Nationwide Incidence of Primary Intracerebral HemorrhageAbdulaziz T Bako, Alan Pan, Thomas Potter, et al.
Vascular and Endovascular Surgery|June 5, 2016
Long-Term Outcomes of Single-Port Laparoscopic Placement of Peritoneal Dialysis CatheterAlan Pan, Mun J Poi, Jesus Matos, et al.
Psychoneuroendocrinology|December 28, 2005
L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRIStephen L Lowe, Kwee Poo Yeo, Leyan Teng, et al.
Journal of the American Heart Association|May 9, 2023
Geographic Disparities in Case Fatality and Discharge Disposition Among Patients With Primary Intracerebral HemorrhageAbdulaziz T Bako, Thomas Potter, Alan Pan, et al.
British Journal of Clinical Pharmacology|April 20, 2004
Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteersTeng C Hua, Alan Pan, Clark Chan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 6, 2022
COVID-19 associated disruptions in routine health care of people with mild cognitive impairment or dementiaJonika Tannous, Alan Pan, Abdulaziz Bako, et al.
BMC Public Health|September 4, 2023
Cumulative social disadvantage and health-related quality of life: national health interview survey 2013-2017Kobina Hagan, Zulqarnain Javed, Miguel Cainzos-Achirica, et al.
Clinical Pharmacology and Therapeutics|March 7, 2003
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteersMichael H Skinner, Han-Yi Kuan, Alan Pan, et al.
JACC. Advances|January 13, 2025
Interplay Between Residential Nature Exposure and Walkability and Their Association with Cardiovascular HealthOmar M Makram, Nwabunie Nwana, Alan Pan, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|September 13, 2021
Cognitive Impairment After Intracerebral Hemorrhage: A Systematic Review of Current Evidence and Knowledge GapsThomas Potter, Vasileios-Arsenios Lioutas, Mauricio Tano, et al.
Stroke|February 3, 2022
Contemporary Trends in the Nationwide Incidence of Primary Intracerebral HemorrhageAbdulaziz T Bako, Alan Pan, Thomas Potter, et al.
Vascular and Endovascular Surgery|June 5, 2016
Long-Term Outcomes of Single-Port Laparoscopic Placement of Peritoneal Dialysis CatheterAlan Pan, Mun J Poi, Jesus Matos, et al.
Psychoneuroendocrinology|December 28, 2005
L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRIStephen L Lowe, Kwee Poo Yeo, Leyan Teng, et al.
Journal of the American Heart Association|May 9, 2023
Geographic Disparities in Case Fatality and Discharge Disposition Among Patients With Primary Intracerebral HemorrhageAbdulaziz T Bako, Thomas Potter, Alan Pan, et al.
British Journal of Clinical Pharmacology|April 20, 2004
Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteersTeng C Hua, Alan Pan, Clark Chan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 6, 2022
COVID-19 associated disruptions in routine health care of people with mild cognitive impairment or dementiaJonika Tannous, Alan Pan, Abdulaziz Bako, et al.
BMC Public Health|September 4, 2023
Cumulative social disadvantage and health-related quality of life: national health interview survey 2013-2017Kobina Hagan, Zulqarnain Javed, Miguel Cainzos-Achirica, et al.
Clinical Pharmacology and Therapeutics|March 7, 2003
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteersMichael H Skinner, Han-Yi Kuan, Alan Pan, et al.
JACC. Advances|January 13, 2025
Interplay Between Residential Nature Exposure and Walkability and Their Association with Cardiovascular HealthOmar M Makram, Nwabunie Nwana, Alan Pan, et al.
Pageof 3